Severe soft tissue infection caused by a non-beta-hemolytic Streptococcus pyogenes strain harboring a premature stop

Jonathan Jantsch1, Roman G Gerlach, Armin Ensser

  • 1Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Insights

A non-beta-hemolytic Streptococcus pyogenes strain caused a severe soft tissue infection. A mutation in the sagC gene, crucial for streptolysin S production, was responsible for the loss of hemolytic activity.

Area of Science:

  • Microbiology
  • Infectious Diseases

Background:

  • Streptococcus pyogenes is a significant human pathogen.
  • Beta-hemolysis, mediated by streptolysin S (SLS), is a characteristic feature of many S. pyogenes strains.
  • SLS production is governed by a specific gene cluster, including the sagC gene.

Observation:

  • A clinical isolate of S. pyogenes from a severe soft tissue infection exhibited a non-beta-hemolytic phenotype.
  • Genetic analysis revealed a premature stop codon in the sagC gene of this isolate.
  • The sagC gene is part of the streptolysin S (SLS) biosynthetic operon.

Findings:

  • The identified point mutation in the sagC gene directly correlated with the absence of beta-hemolytic activity.
  • Restoration of a functional sagC gene via plasmid vector reintroduction successfully restored the beta-hemolytic phenotype in the clinical isolate.
  • This confirms that the non-hemolytic nature of the strain was due to the defective sagC gene.

Implications:

  • This study identifies a novel mechanism for S. pyogenes-associated severe soft tissue infections caused by strains lacking hemolytic activity.
  • The findings expand our understanding of S. pyogenes virulence factors and their role in disease pathogenesis.
  • Clinicians should consider non-beta-hemolytic S. pyogenes strains as potential causative agents in severe soft tissue infections.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...